BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36861761)

  • 41. Genetic and molecular pathogenesis of hereditary hemorrhagic telangiectasia.
    Azuma H
    J Med Invest; 2000 Aug; 47(3-4):81-90. PubMed ID: 11019486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Genetic diagnostics of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease)].
    Major T; Gindele R; Szabó Z; Jóni N; Kis Z; Bora L; Bárdossy P; Rácz T; Karosi T; Bereczky Z
    Orv Hetil; 2019 May; 160(18):710-719. PubMed ID: 31030535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease.
    Abdalla SA; Letarte M
    J Med Genet; 2006 Feb; 43(2):97-110. PubMed ID: 15879500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of a significant association between mutations in the ACVRL1 gene and hepatic involvement in German patients with hereditary haemorrhagic telangiectasia.
    Brakensiek K; Frye-Boukhriss H; Mälzer M; Abramowicz M; Bahr MJ; von Beckerath N; Bergmann C; Caselitz M; Holinski-Feder E; Muschke P; Oexle K; Strobl-Wildemann G; Wolff G; El-Harith EA; Stuhrmann M
    Clin Genet; 2008 Aug; 74(2):171-7. PubMed ID: 18498373
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does the genotype of HHT patients with mutations of the ENG and ACVRL1 gene correlate to different expression levels of the angiogenic factor VEGF?
    Sadick H; Hage J; Goessler U; Bran G; Riedel F; Bugert P; Hoermann K
    Int J Mol Med; 2008 Nov; 22(5):575-80. PubMed ID: 18949376
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The clinical and genetic features of hereditary haemorrhagic telangiectasia (HHT) in central South Africa-three novel pathogenic variants.
    Mutize TT; Seedat RY; Ploos van Amstel JK; Mager JJ; Brown SC; Gebremariam F; Coetzee MJ
    Mol Biol Rep; 2020 Dec; 47(12):9967-9972. PubMed ID: 33201366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutational and clinical spectrum of Japanese patients with hereditary hemorrhagic telangiectasia.
    Kitayama K; Ishiguro T; Komiyama M; Morisaki T; Morisaki H; Minase G; Hamanaka K; Miyatake S; Matsumoto N; Kato M; Takahashi T; Yorifuji T
    BMC Med Genomics; 2021 Dec; 14(1):288. PubMed ID: 34872578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long non-coding RNA expression profiles in hereditary haemorrhagic telangiectasia.
    Tørring PM; Larsen MJ; Kjeldsen AD; Ousager LB; Tan Q; Brusgaard K
    PLoS One; 2014; 9(3):e90272. PubMed ID: 24603890
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia.
    Letteboer TG; Mager JJ; Snijder RJ; Koeleman BP; Lindhout D; Ploos van Amstel JK; Westermann CJ
    J Med Genet; 2006 Apr; 43(4):371-7. PubMed ID: 16155196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A hereditary haemorrhagic telangiectasia family with pulmonary involvement is unlinked to the known HHT genes, endoglin and ALK-1.
    Wallace GM; Shovlin CL
    Thorax; 2000 Aug; 55(8):685-90. PubMed ID: 10899246
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induced Endothelial Cell Cycle Arrest Prevents Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia.
    Genet G; Genet N; Paila U; Cain SR; Cwiek A; Chavkin NW; Serbulea V; Figueras A; Cerdà P; McDonnell SP; Sankaranarayanan D; Huba M; Nelson EA; Riera-Mestre A; Hirschi KK
    Circulation; 2024 Mar; 149(12):944-962. PubMed ID: 38126211
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Loss of Endothelial Endoglin Promotes High-Output Heart Failure Through Peripheral Arteriovenous Shunting Driven by VEGF Signaling.
    Tual-Chalot S; Garcia-Collado M; Redgrave RE; Singh E; Davison B; Park C; Lin H; Luli S; Jin Y; Wang Y; Lawrie A; Jakobsson L; Arthur HM
    Circ Res; 2020 Jan; 126(2):243-257. PubMed ID: 31805812
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatic angiodynamic profile in paediatric patients with hereditary haemorrhagic telangiectasia type 1 and type 2.
    Giordano P; Francavilla M; Buonamico P; Suppressa P; Lastella P; Sangerardi M; Miniello VL; Scardapane A; Lenato GM; Sabbà C
    Vasa; 2017 May; 46(3):195-202. PubMed ID: 28248153
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Common and distinctive pathogenetic features of arteriovenous malformations in hereditary hemorrhagic telangiectasia 1 and hereditary hemorrhagic telangiectasia 2 animal models--brief report.
    Garrido-Martin EM; Nguyen HL; Cunningham TA; Choe SW; Jiang Z; Arthur HM; Lee YJ; Oh SP
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2232-6. PubMed ID: 25082229
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brain arteriovenous malformations associated with hereditary hemorrhagic telangiectasia: gene-phenotype correlations.
    Nishida T; Faughnan ME; Krings T; Chakinala M; Gossage JR; Young WL; Kim H; Pourmohamad T; Henderson KJ; Schrum SD; James M; Quinnine N; Bharatha A; Terbrugge KG; White RI
    Am J Med Genet A; 2012 Nov; 158A(11):2829-34. PubMed ID: 22991266
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hereditary hemorrhagic telangiectasia: an update on clinical manifestations and diagnostic measures.
    Sadick H; Sadick M; Götte K; Naim R; Riedel F; Bran G; Hörmann K
    Wien Klin Wochenschr; 2006 Mar; 118(3-4):72-80. PubMed ID: 16703249
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of pulmonary arteriovenous malformations in ACVRL1 versus ENG mutation carriers in hereditary hemorrhagic telangiectasia.
    Mu W; Cordner ZA; Yuqi Wang K; Reed K; Robinson G; Mitchell S; Lin D
    Genet Med; 2018 Jun; 20(6):639-644. PubMed ID: 29048420
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathogenesis of arteriovenous malformations in the absence of endoglin.
    Mahmoud M; Allinson KR; Zhai Z; Oakenfull R; Ghandi P; Adams RH; Fruttiger M; Arthur HM
    Circ Res; 2010 Apr; 106(8):1425-33. PubMed ID: 20224041
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of a mutation in the zona pellucida module of Endoglin that causes Hereditary Hemorrhagic Telangiectasia.
    Ruiz-Llorente L; Chiapparino E; Plumitallo S; Danesino C; Bayrak-Toydemir P; Pagella F; Manfredi G; Bernabeu C; Jovine L; Olivieri C
    Gene; 2019 May; 696():33-39. PubMed ID: 30763665
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain.
    Xu B; Wu YQ; Huey M; Arthur HM; Marchuk DA; Hashimoto T; Young WL; Yang GY
    J Cereb Blood Flow Metab; 2004 Feb; 24(2):237-44. PubMed ID: 14747750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.